SABCS 2016: systemic therapy for metastatic breast cancer

At the 2016 San Antonio Breast Cancer Symposium, several interesting phase II and phase III studies investigating systemic therapies for metastatic breast cancer were presented. The PrEGOC 0102 trial demonstrated that the combination of fulvestrant plus everolimus is safe and effective and could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Short Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493725/
https://www.ncbi.nlm.nih.gov/pubmed/28725277
http://dx.doi.org/10.1007/s12254-017-0326-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493725/
https://www.ncbi.nlm.nih.gov/pubmed/28725277
http://dx.doi.org/10.1007/s12254-017-0326-4

Ejemplares similares